Answer
Elevated liver transaminases and hepatitis have been reported with isavuconazonium sulfate (Cresemba); transaminase elevations rarely required discontinuation of isavuconazole, and hepatic enzyme monitoring should be considered as clinically indicated.
Sources for this answer
- CRESEMBA 200mg Powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 22Document updated
Sources checked